Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1)
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Surgery"
DOI: 10.1007/s00268-018-4839-8
Abstract: ObjectiveLong-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms. We evaluated the chemopreventive effects of a long-acting somatostatin analogue on the development of pancreatic neuroendocrine neoplasms (pNENs) in a… read more here.
Keywords: pancreatic neuroendocrine; neuroendocrine neoplasms; group; men1 ... See more keywords